文献速递生殖医学

尿液氧化应激标志物与不孕治疗夫妇生殖结局的关系

Urinary oxidative stress biomarker levels and reproductive outcomes among couples undergoing fertility treatments.
PubMed 文献 · Hum Reprod · 2019-01-01

该前瞻性队列纳入2007–2015年波士顿EARTH研究中481名接受生育治疗的女性及其249名男性伴侣,每周期采集尿样检测8-iso-PGF2α与F2-isoP-M。女性F2-isoP-M中间三分位与最高生殖成功相关,男性标志物与伴侣结局无显著关联。

要点

  • 女性F2-isoP-M中间三分位活产率38%,高于上三分位23%和下三分位27%。
  • 女性8-iso-PGF2α中间三分位IVF受精率0.77,高于下三分位0.69和上三分位0.66。
  • 男性任何氧化应激标志物与伴侣生殖结局均无显著关联。

核心结论

  • 女性F2-isoP-M中间三分位与最高生殖成功率相关,男性标志物与伴侣结局无显著关联。
  • 研究提示在接受生育治疗人群中氧化应激与生殖结局可能存在非线性关联。

研究设计与样本

  • 前瞻性队列研究,纳入2007至2015年波士顿EARTH研究中481名接受生育治疗的女性及249名男性伴侣。
  • 每周期每人采集一份尿样,检测8-iso-PGF2α和F2-isoP-M两种氧化应激标志物。
  • 采用聚类加权广义估计方程分析暴露三分位与结局的校正关联。

主要发现

  • 女性F2-isoP-M上三分位IVF和IUI后校正平均活产率23%(95%CI:17,29),中间三分位38%(95%CI:31,45),下三分位27%(95%CI:21,34)。
  • 女性8-iso-PGF2α中间三分位IVF受精率0.77(95%CI:0.73,0.80),高于下三分位0.69(95%CI:0.64,0.73)和上三分位0.66(95%CI:0.61,0.71)。
  • 8-iso-PGF2α与其他测量结局无显著关联,男性任何氧化应激标志物与伴侣生殖结局无显著关联。

临床怎么用

  • 在接受生育治疗女性中,F2-isoP-M中间三分位与最高活产率相关,上三分位活产率低于中间三分位。
  • 女性8-iso-PGF2α中间三分位IVF受精率高于下三分位和上三分位。
  • 男性氧化应激标志物水平与伴侣生殖结局无显著关联。

局限性

  • 异前列腺素为短寿命标志物,本研究可能未捕捉到氧化应激对结局最相关的易感窗口。
  • 研究结果可能不适用于未接受生育辅助的尝试怀孕夫妇。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are urinary levels of oxidative stress biomarkers associated with reproductive outcome success following fertility treatments? SUMMARY ANSWER: Levels of oxidative stress in the middle tertile for women are associated with the highest levels of reproductive success while no associations were noted for men. WHAT IS KNOWN ALREADY: Oxidative stress may contribute to adverse fertility outcomes in the general population, but findings from couples undergoing fertility treatments are sparse. STUDY DESIGN, SIZE, DURATION: This prospective cohort study included 481 women and 249 of their male partners undergoing fertility treatments from 2007 to 2015, from the Environment and Reproductive Health (EARTH) study in Boston, MA. PARTICIPANTS/MATERIALS, SETTING, METHODS: One urine sample per participant was collected at each cycle and analysed for two oxidative stress markers: 8-isoprostane-PGF2α (8-iso-PGF2α) and 8-isoprostane-PGF2α metabolite (F2-isoP-M). Reproductive outcomes were abstracted from medical records and included the fertilization rate, for IVF (oocytes fertilized/mature oocytes retrieved), and rates of implantation, clinical pregnancy and live birth, for both IVF and IUI. Cluster-weighted generalized estimating equations were used to analyse adjusted associations between exposure tertiles and outcomes. MAIN RESULTS AND THE ROLE OF CHANCE: Levels of F2-isoP-M in the middle tertile were associated with the most success among women. Women in the upper tertile of F2-isoP-M had an adjusted mean live birth rate after IVF and IUI of 23% (95% CI: 17, 29) compared to 38% (95% CI: 31, 45) for women in the middle tertile and 27% (95% CI: 21, 34) in the lower tertile. The fertilization rate during IVF was higher for women with 8-iso-PGF2α in the middle tertile (0.77 [95% CI: 0.73, 0.80]) compared to women in the lower (0.69 [95% CI: 0.64, 0.73]) or upper tertiles (0.66 [95% CI: 0.61, 0.71]). No significant associations were found for other measured outcomes with 8-iso-PGF2α, or between any oxidative stress biomarker in men and reproductive outcomes in their partners. LIMITATIONS, REASONS FOR CAUTION: Isoprostanes are short-lived biomarkers and this study may not have captured the most relevant window of susceptibility for oxidative stress on the outcomes of interest. Findings from this study may not be generalizable to couples attempting conception without fertility assistance. WIDER IMPLICATIONS OF THE FINDINGS: This study suggests that a non-linear association may exist between oxidative stress and reproductive outcomes in a population undergoing fertility treatment, a finding not previously identified in the literature. Oxidative stress may represent the mechanism through which environmental chemicals are associated with adverse reproductive outcomes. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the Intramural Research Program of the National Institutes of Environmental Health Sciences (NIEHS) (ZIA ES103314) and by NIEHS grants R01ES022955, R01ES009718 and R01ES00002. There are no competing interests to report. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Rosen EM, Mínguez-Alarcón L, Meeker JD, et al. Urinary oxidative stress biomarker levels and reproductive outcomes among couples undergoing fertility treatments. Hum Reprod. 2019. PMID: 31887223. doi:10.1093/humrep/dez228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。